The glycine transporter inhibitor Org 25935 prevents ethanol-induced elevations of dopamine levels in the nucleus accumbens of the rat

被引：0
|
作者：
Hoifodt, H.
Molander, A.
Stomberg, R.
Ericson, M.
Soderpalm, B.
机构：
[1] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Phyiol, Sect Psychiat & Neurochem, Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Beroendekliniken, S-41345 Gothenburg, Sweden
来源：
NORDIC JOURNAL OF PSYCHIATRY | 2006年 / 60卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
P-09
引用
下载
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
  • [41] Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone
    Nagy, Katalin
    Marko, Bernadett
    Zsilla, Gabriella
    Matyus, Peter
    Pallagi, Katalin
    Szabo, Geza
    Juranyi, Zsolt
    Barkoczy, Jozsef
    Levay, Gyorgy
    Harsing, Laszlo G., Jr.
    NEUROCHEMICAL RESEARCH, 2010, 35 (12) : 2096 - 2106
  • [42] Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone
    Katalin Nagy
    Bernadett Marko
    Gabriella Zsilla
    Peter Matyus
    Katalin Pallagi
    Geza Szabo
    Zsolt Juranyi
    Jozsef Barkoczy
    Gyorgy Levay
    Laszlo G. Harsing
    Neurochemical Research, 2010, 35 : 2096 - 2106
  • [43] Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcohol-preferring rats: Effects on dialysate dopamine levels and ethanol intake
    Engleman, EA
    McBride, WJ
    Wilber, AA
    Shaikh, SR
    Eha, RD
    Lumeng, L
    Li, TK
    Murphy, JM
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2000, 24 (06) : 795 - 801
  • [44] Ethanol-induced fos immunoreactivity in the extended amygdala and hypothalamus of the rat brain: Focus on cholinergic interneurons of the nucleus accumbens
    Herring, BE
    Mayfield, RD
    Camp, MC
    Alcantara, AA
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (04) : 588 - 597
  • [45] Sub-chronic taurine administration induces behavioral sensitization but does not influence ethanol-induced dopamine release in the nucleus accumbens
    Ulenius, Lisa
    Andren, Anna
    Adermark, Louise
    Soderpalm, Bo
    Ericson, Mia
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2020, 188
  • [46] Involvement of dopamine D1 receptors in the expression of ethanol-induced behavioral sensitization: Essential role of the nucleus accumbens.
    Abrahao, K. P.
    Quadros, I. M. H.
    Souza-Formigoni, M. L. O.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 81A - 81A
  • [47] The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens
    Velazquez-Sanchez, Clara
    Garcia-Verdugo, Jose M.
    Murga, Juan
    Canales, Juan J.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 44 : 73 - 80
  • [48] IN VIVO ANALYSIS OF ETHANOL-INDUCED CHANGES IN SYNAPTIC FIRING AND DOPAMINE RELEASE IN THE NUCLEUS ACCUMBENS AND VENTRAL TEGMENTAL AREA OF AWAKE AND FREELY MOVING RODENTS
    Burkhardt, J. M.
    Clarke, R. B. C.
    Ericson, M.
    Soderpalm, B.
    Costa, R. M.
    Adermark, L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 124A - 124A
  • [49] The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats
    Scherma, Maria
    Justinova, Zuzana
    Zanettini, Claudio
    Panlilio, Leigh V.
    Mascia, Paola
    Fadda, Paola
    Fratta, Walter
    Makriyannis, Alexandros
    Vadivel, Subramanian K.
    Gamaleddin, Islam
    Le Foll, Bernard
    Goldberg, Steven R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 165 (08) : 2539 - 2548
  • [50] Differential effects of chronic imipramine and fluoxetine on basal and amphetamine-induced extracellular dopamine levels in rat nucleus accumbens
    Ichikawa, J
    Kuroki, T
    Meltzer, HY
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 350 (2-3) : 159 - 164
12345